Chandra P Belani MD

Summary

• Chandra Belani, MD led clinical and translational research to develop novel therapeutic strategies that have been approved by regulatory agencies across the world and adopted as ‘standards of care’ for the management of lung cancer. His work and a positive, motivational and enthusiastic style driven by the need to ‘make a difference’ has impacted every lung cancer patient’s journey across the globe. With extensive contributions to the literature, he had the world stage to talk about his accomplishments. I has nurtured the careers of a number of investigators who have now advanced to prestigious positions in academia, clinical and translational medicine and industry. More recently, his research focus evolved to “Lipid nanoprobe integrated microdevice for extracellular vesicle isolation and duplex sequencing-based mutation detection for non-invasive lung cancer diagnosis” and utilizing proteomics and flow cytometry to measure immune cells in the tumor microenvironment in an attempt to gain deeper biological insights. In addition, working with Bioinformatics and Data Sciences his group is developing optimal methods utilizing Artificial Intelligence and Deep Learning including visual analytic tools to navigate the vast health information "terrain" as it relates to lung cancer.